Asieris Pharmaceutical Technologies Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Asieris Pharmaceutical Technologies Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment (NCT03672240) | Asieris Pharmaceutical Technologies Co., Ltd. | 2018-11-30 |
Track Asieris Pharmaceutical Technologies Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.